OLMA Olema Pharmaceuticals, Inc.

Fundamentals / CIK 0001750284 / USD

Olema Pharmaceuticals, Inc. reported $441.1M in total assets and a net loss of $235.9M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OLMA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$151.9MFY 2019 Net Income: -$4.32M2019FY 2020 Net Income: -$22.12M2020FY 2021 Net Income: -$71.10M2021FY 2022 Net Income: -$104.8M2022FY 2023 Net Income: -$96.66M2023FY 2024 Net Income: -$129.5M2024FY 2025 Net Income: -$162.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $157.7M $124.5M $86.14M $82.27M $51.10M $13.70M $3.92M
Total Operating Expenses $178.7M $142.3M $105.0M $107.0M $71.49M $21.53M $4.32M
Operating Income -$178.7M -$142.3M -$105.0M -$107.0M -$71.49M -$21.53M -$4.32M
EBITDA -$178.2M -$141.9M -$104.6M -$106.6M -$71.33M -$21.52M -$4.31M
Interest Income $16.22M $12.68M $8.32M $2.23M $442K $60K $7.0K
Interest Expense -- -- -- -- -- $653K --
Income Before Tax -$162.4M -$129.5M -- -- -- -- --
Income Tax Expense $3.0K $2.0K $2.0K $1.0K -- -- --
Net Income -$162.5M -$129.5M -$96.66M -$104.8M -$71.10M -$22.12M -$4.32M
Basic EPS -$1.87 -$2.20 -$2.14 -$2.62 -$1.80 -$3.42 -$1.66
Diluted EPS -$1.87 -$2.20 -$2.14 -$2.62 -$1.80 -$3.42 -$1.66
Basic Shares Outstanding 87.0M 58.7M 45.2M 40.0M 39.5M 7.0M 2.6M
Diluted Shares Outstanding 87.0M 58.7M 45.2M 40.0M 39.5M 7.0M 2.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $67.60M $57.78M $49.23M $43.22M $39.95M $43.90M $30.62M $32.30M
Total Operating Expenses $77.53M $67.18M $57.99M $50.08M $45.88M $47.86M $34.87M $36.77M
Operating Income -$77.53M -$67.18M -$57.99M -$50.08M -$45.88M -$47.86M -$34.87M -$36.77M
EBITDA -$77.43M -$67.08M -$57.87M -$49.90M -$45.83M -$47.73M -$34.74M -$36.65M
Interest Income $4.05M $4.51M $4.78M $4.01M $3.65M $4.04M $4.52M $3.29M
Net Income -$73.60M -$63.20M -$53.09M -$46.06M -$42.22M -$43.78M -$30.39M -$33.57M
Basic EPS -$0.73 -$0.61 -$0.52 -- -$0.49 -$0.51 -$0.36 --
Diluted EPS -$0.73 -$0.61 -$0.52 -- -$0.49 -$0.51 -$0.36 --
Basic Shares Outstanding 101.1M 104.5M 102.8M -- 85.7M 85.5M 85.4M --
Diluted Shares Outstanding 101.1M 104.5M 102.8M -- 85.7M 85.5M 85.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $48.30M $139.5M $68.54M $23.70M $13.81M $338.5M
Short-Term Investments $457.1M $294.6M $193.3M $180.7M $273.4M --
Cash & Short-Term Investments $505.4M $434.1M $261.8M $204.4M $287.3M $338.5M
Total Current Assets $515.5M $438.5M $266.5M $208.9M $290.7M $342.1M
Property, Plant & Equipment, Net $274K $746K $968K $1.48M $1.47M $75K
Other Non-Current Assets -- $15K -- $2.77M $540K $510K
Total Non-Current Assets $17.98M $12.51M $10.43M $6.75M $5.26M $585K
Total Assets $533.4M $451.0M $276.9M $215.6M $295.9M $342.7M
Accounts Payable $9.25M $4.46M $2.70M $374K $23K $719K
Other Current Liabilities $41.42M $36.13M $17.93M $15.16M $8.06M $3.87M
Total Current Liabilities $51.80M $41.76M $21.62M $16.55M $9.02M $4.58M
Total Non-Current Liabilities $3.07M $257K $1.43M $1.55M $2.36M $0
Total Liabilities $54.87M $42.02M $23.05M $18.10M $11.38M $4.58M
Total Debt (incl. Leases) $1.19M $1.43M $2.42M $2.56M $3.29M --
Common Stock $8.0K $7.0K $4.0K $3.0K $3.0K $3.0K
Retained Earnings -$597.6M -$435.1M -$305.6M -$209.0M -$104.2M -$33.09M
Accumulated Other Comp. Income $621K $143K $347K -$1.81M -$149K --
Total Stockholders' Equity $478.6M $409.0M $253.9M $197.5M $284.6M $338.1M
Total Equity $478.6M $409.0M $253.9M $197.5M $284.6M $338.1M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $47.52M $48.60M $52.55M $48.30M $35.26M $52.47M $50.64M $139.5M
Short-Term Investments $366.2M $412.5M $452.8M $457.1M $293.7M $309.4M $342.1M $294.6M
Cash & Short-Term Investments $413.8M $461.1M $505.3M $505.4M $329.0M $361.9M $392.7M $434.1M
Total Current Assets $423.4M $469.9M $513.2M $515.5M $334.3M $367.7M $396.7M $438.5M
Property, Plant & Equipment, Net $1.65M $382K $356K $274K $486K $560K $653K $746K
Other Non-Current Assets -- -- -- -- -- $15K $14K $15K
Total Non-Current Assets $17.64M $16.70M $17.42M $17.98M $18.12M $14.28M $12.98M $12.51M
Total Assets $441.1M $486.6M $530.6M $533.4M $352.5M $382.0M $409.6M $451.0M
Accounts Payable $1.21M $1.67M $3.72M $9.25M $3.47M $934K $151K $4.46M
Other Current Liabilities $67.67M $50.69M $42.49M $41.42M $37.01M $31.08M $24.89M $36.13M
Total Current Liabilities $69.23M $53.01M $47.17M $51.80M $41.66M $33.16M $26.06M $41.76M
Total Non-Current Liabilities $3.00M $3.00M $3.00M $3.07M $3.31M $3.60M $123K $257K
Total Liabilities $72.23M $56.01M $50.17M $54.87M $44.97M $36.77M $26.19M $42.02M
Total Debt (incl. Leases) $356K $660K $956K $1.19M $1.48M $1.75M $1.15M $1.43M
Common Stock $8.0K $8.0K $8.0K $8.0K $7.0K $7.0K $7.0K $7.0K
Retained Earnings -$787.4M -$713.8M -$650.6M -$597.6M -$551.5M -$509.3M -$465.5M -$435.1M
Accumulated Other Comp. Income -$1.59M -$947K -$460K $621K $526K $314K $420K $143K
Total Stockholders' Equity $368.8M $430.6M $480.5M $478.6M $307.5M $345.2M $383.5M $409.0M
Total Equity $368.8M $430.6M $480.5M $478.6M $307.5M $345.2M $383.5M $409.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$162.5M -$129.5M -$96.66M -$104.8M -$71.10M -$22.12M -$4.32M
Depreciation & Amortization $490K $393K $377K $357K $163K $11K $9.0K
Stock-Based Compensation $17.59M $22.58M $17.26M $18.83M $15.91M $3.11M --
Change in Payables $4.60M $2.51M $2.32M $351K -$683K -$220K $810K
Operating Cash Flow -$146.7M -$104.4M -$83.73M -$82.06M -$50.69M -$19.87M -$3.08M
Capital Expenditure -- -$159K -- -$363K -$1.57M -$56K --
Free Cash Flow -- -$104.5M -- -$82.43M -$52.27M -$19.92M --
Purchases of Investments -$500.7M -$395.0M -$255.6M -$213.7M -$487.0M -- --
Investing Cash Flow -$155.8M -$93.53M -$4.85M $91.48M -$275.4M -$56K --
Financing Cash Flow $211.3M $268.8M $133.4M $476K $1.39M $358.4M --
Net Change in Cash -$91.18M $70.94M $44.84M $9.89M -$324.7M $338.5M -$3.08M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$73.60M -$63.20M -$53.09M -$46.06M -$42.22M -$43.78M -$30.39M -$33.57M
Depreciation & Amortization $94K $102K $119K $187K $43K $132K $128K $116K
Stock-Based Compensation $12.08M $12.90M $10.15M $4.27M $4.25M $4.69M $4.38M $6.32M
Change in Payables -$458K -$1.91M -$5.68M $5.77M $2.39M $743K -$4.31M $2.52M
Operating Cash Flow -$47.11M -$45.90M -$45.99M -$38.33M -$34.53M -$29.88M -$43.98M -$26.28M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$26.28M
Purchases of Investments -$50.77M -$48.24M -$69.94M -$253.4M -$71.65M -$32.86M -$142.9M -$189.2M
Investing Cash Flow $45.60M $40.84M $4.53M -$162.2M $17.27M $34.23M -$45.08M -$114.4M
Financing Cash Flow $434K $1.11M $45.70M $213.6M $41K -$2.52M $222K $244.3M
Net Change in Cash -$1.08M -$3.95M $4.25M $13.04M -$17.21M $1.83M -$88.84M $103.6M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -33.9% -31.7% -38.1% -53.0% -25.0% -6.5% --
Return on Assets (ROA) -30.5% -28.7% -34.9% -48.6% -24.0% -6.5% --
Current Ratio 9.95x 10.50x 12.33x 12.62x 32.23x 74.62x --
Quick Ratio 9.76x 10.40x 12.11x 12.35x 31.85x 73.84x --
Debt to Equity 0.00x 0.00x 0.01x 0.01x 0.01x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -64.0% -47.5% -38.5% -33.9% -48.8% -41.2% -33.6% -31.7%
Return on Assets (ROA) -53.5% -42.0% -34.9% -30.5% -42.5% -37.2% -31.5% -28.7%
Current Ratio 6.12x 8.86x 10.88x 9.95x 8.03x 11.09x 15.22x 10.50x
Quick Ratio 5.98x 8.70x 10.71x 9.76x 7.90x 10.91x 15.07x 10.40x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001750284) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:34 UTC · Open in terminal